JPRN-UMIN000040147
Recruiting
N/A
Subepithelial injection of onabotulinumtoxin A for overactive bladder - Onabotulinumtoxin A injection in overactive bladder
Hokusuikai kinen Hospital Department of Urology0 sites40 target enrollmentMay 1, 2020
ConditionsRefractory overactive bladder
Overview
- Phase
- N/A
- Intervention
- Not specified
- Conditions
- Refractory overactive bladder
- Sponsor
- Hokusuikai kinen Hospital Department of Urology
- Enrollment
- 40
- Status
- Recruiting
- Last Updated
- 2 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- Not provided
Exclusion Criteria
- •1\) The patient has apparent neurogenic diseases causing urinary tract symptoms. 2\) The patient underwent treatment with botulinum toxin A. 3\) The patient underwent the surgery of lower urinary tract within 1 year. 4\) Postvoid residual urine is 100mL or greater. 5\) The patient has apparent lower urinary tract obstruction and/or weak detrusor. 6\) The patient has predominantly stress urinary incontinence. 7\) The patient has active urinary tract infection, malignance and/or bladder stone. 8\) The patient is pregnant or breast\-feed, or have possibility of such matter within 1 year. 9\) The patient is diagnosed as having myasthenia gravis, Lambert\-Eaton syndromeconduct , amyotrophic lateral sclerosis. 10\)The patient has disturbance of swallowing and/or respiration. 11\)The patient has mental and/or cognitive disturbance to conduct the clinical trial. 12\) The patient is judged as being unsuitable for the trial by the researcher.
Outcomes
Primary Outcomes
Not specified
Similar Trials
Completed
N/A
Subepithelial injection of botulinum toxin A for non-neurogecic overactive bladderon-neurogenic overactive bladderJPRN-UMIN000001422ational Center for Geriatrics & Gerontology45
Completed
N/A
Subepithelial injection of botulinum toxin A for neurogecic detrusor overactivity (NDO) due to spinal cord injuryeurogenic detrusor overactivityJPRN-UMIN000001421ational Center for Geriatrics & Gerontology26
Recruiting
Phase 1
Perineural injections of incobotulinumtoxin-A for diabetic neuropathic pain of the lower extremities: A double-blind, randomized, placebo-controlled study (PINBOT)Diabetic neuropathic painMedDRA version: 21.1Level: LLTClassification code: 10067547Term: Diabetic peripheral neuropathic pain Class: 10029205Therapeutic area: Diseases [C] - Nervous System Diseases [C10]Therapeutic area: Diseases [C] - Nutritional and Metabolic Diseases [C18]CTIS2022-500727-68-01Rigshospitalet80
Not Yet Recruiting
Phase 2
Injection Botulinum Toxin in post-surgery wound healingHealth Condition 1: C00-C14- Malignant neoplasms of lip, oral cavity and pharynxCTRI/2024/03/064416Intraumural Grant
Active, Not Recruiting
N/A
Intraprostatic injection of Botulinumtoxin type A in patients with chronic prostatitis / chronic pelvic pain syndrome (CP/CPPS) - CP(BTX)PSEUCTR2007-001602-24-DEDepartment of Urology and Pediatric Urology - Justus-Liebig-University Giessen